In 2023, stomach malignant neoplasms mortality among females in the US stood at a specific benchmark prior to the forecasted period. Data from 2024 to 2028 indicates a gradual increase in female mortality due to this cause, from 4.54 thousand in 2024 to 4.57 thousand in 2028. Year-on-year, this reflects marginal growth, underlined by minor percentage increases annually. As we look from 2024 to 2028, the compound annual growth rate (CAGR) illustrates a slow yet persistent upward trend, emphasizing a need for sustained monitoring and intervention.
Future trends to watch for:
- Increases in early detection and prevention strategies.
- Growth of innovative treatments and interventions.
- The demographic and lifestyle shifts impacting prevalence and mortality rates.
- Technological advances in healthcare and their potential to reduce mortality.
